Last news
Invitation to webcast about UPM’s growth and innovation in

Invitation to webcast about UPM’s growth and innovation in

(UPM, Helsinki, 1 March 2023 at 10:00 EET) – UPM will arrange a webcast about its growth and product innovation in specialty packaging materials for......

Mainz Biomed Recognizes Colorectal Cancer Awareness Month

Mainz Biomed Recognizes Colorectal Cancer Awareness Month

Mainz Biomed to host several events for patients and healthcare professionals in Germany to increase awareness about the importance of early detection of......

New CEO appointed in “Barbora” controlled by MAXIMA GRUPĖ

New CEO appointed in “Barbora” controlled by MAXIMA GRUPĖ

From Wednesday, 1st of March, 2023, Viktoras Juozapaitis is appointed as General Manager (CEO) of RADAS, UAB and UAB “Barbora”. Viktoras Juozapaitis has......

Solvay highlights innovation and growth opportunities in

Solvay highlights innovation and growth opportunities in

Solvay highlights innovation and growth opportunities in Aerospace & Defense market The Group held a webinar focused on activities in its Composite......

Andres Maasing appointed as the new Member of the

Andres Maasing appointed as the new Member of the

The Supervisory Board of Enefit Green has appointed Andres Maasing as a Member of the Management Board of Enefit Green. Andres Maasing will take up the......

Efecte Plc Launches a New Employee Share Savings Plan 

Efecte Plc Launches a New Employee Share Savings Plan 

EFECTE PLC -- COMPANY ANNOUNCEMENT – 1 March 2023 at 9:00 am EFECTE PLC LAUNCHES A NEW EMPLOYEE SHARE SAVINGS PLAN The Board of Directors of......

Notification under Chapter 9, Section 10 of the Finnish

Notification under Chapter 9, Section 10 of the Finnish

OMA SAVINGS BANK PLC, STOCK EXCHANGE RELEASE 1 MARCH 2023 AT 08:30 A.M. EET, MAJOR SHAREHOLDER ANNOUNCEMENT Notification under Chapter 9, Section 10 of......

Sequana Medical announces positive results from CHIHUAHUA,

Sequana Medical announces positive results from CHIHUAHUA,

PRESS RELEASE Phase 1 clinical trial (CHIHUAHUA) demonstrates that single dose of second-generation DSR product (DSR 2.0) is safe and well-tolerated,......

1 ... 779 780 781 782 783 784 785 786 787 ... 1011
menu
menu